Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Heart Failure

  Free Subscription


20.03.2023

3 Am J Cardiol
2 Chest
1 Circ Cardiovasc Qual Outcomes
3 Circulation
5 Eur Heart J
6 Eur J Heart Fail
3 Heart
7 Int J Cardiol
4 J Card Fail
1 J Cardiol
1 J Thorac Cardiovasc Surg
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. ROBERTS WC, Jayanthi S, Jeong M
    Severe Heart Failure Resulting From Healed Myocardial Infarction Preferentially Involving the Ventricular Septum and Leading to Orthotopic Heart Transplantation.
    Am J Cardiol. 2023;193:111-117.
    PubMed         Abstract available

  2. AGARWAL S, Ul Abideen Asad Z, Akella K, Clifton S, et al
    Meta-Analysis on the Impact of Ventricular Arrhythmias on Mortality in Patients With Continuous Flow Left Ventricular Assist Devices.
    Am J Cardiol. 2023;192:139-146.
    PubMed         Abstract available

  3. EGBE AC, Miranda WR, Stephens EH, Anderson JH, et al
    Right Ventricular Systolic Dysfunction in Adults With Anatomic Repair of d-Transposition of Great Arteries.
    Am J Cardiol. 2023;192:101-108.
    PubMed         Abstract available


    Chest

  4. ZHENG J, Zhou R, Zhang Y, Su K, et al
    Preserved Ratio Impaired Spirometry in Relation to Cardiovascular Outcomes: A Large Prospective Cohort Study.
    Chest. 2022 Nov 10. pii: S0012-3692(22)04064-8. doi: 10.1016/j.chest.2022.
    PubMed         Abstract available

  5. MARON BA, Kleiner DE, Arons E, Wertheim BM, et al
    Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy with Pulmonary Hypertension.
    Chest. 2022 Oct 12. pii: S0012-3692(22)03912-5. doi: 10.1016/j.chest.2022.
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  6. SANDHU AT, Zheng J, Skye M, Heidenreich PA, et al
    Updating the Accuracy of Administrative Claims for Identifying Left Ventricular Ejection Fraction Among Patients With Heart Failure.
    Circ Cardiovasc Qual Outcomes. 2023 Mar 16:e008919.
    PubMed        


    Circulation

  7. SELVARAJ S, Kosiborod MN, Shah SH
    Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".
    Circulation. 2023;147:922-923.
    PubMed        

  8. TACHIBANA S, Yu NK, Li R, Fernandez-Costa C, et al
    Perm1 Protects the Heart From Pressure Overload-Induced Dysfunction by Promoting Oxidative Metabolism.
    Circulation. 2023;147:916-919.
    PubMed        

  9. MONZO L, Melenovsky V
    Letter by Monzo and Melenovsky Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".
    Circulation. 2023;147:920-921.
    PubMed        


    Eur Heart J

  10. TAYLOR RS, Dalal HM, Zwisler AD
    Cardiac rehabilitation for heart failure: 'Cinderella' or evidence-based pillar of care?
    Eur Heart J. 2023 Mar 11:ehad118. doi: 10.1093.
    PubMed         Abstract available

  11. LUND LH, Hage C, Pironti G, Thorvaldsen T, et al
    Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilization.
    Eur Heart J. 2023 Mar 14:ehad100. doi: 10.1093.
    PubMed         Abstract available

  12. PEDICINO D, Volpe M
    Improving care for heart failure patients by COACHing clinicians to use decision-support tools.
    Eur Heart J. 2023 Mar 16:ehad097. doi: 10.1093.
    PubMed        

  13. VERWERFT J, Soens L, Wynants J, Meysman M, et al
    Heart failure with preserved ejection fraction: relevance of a dedicated dyspnoea clinic.
    Eur Heart J. 2023 Mar 16:ehad141. doi: 10.1093.
    PubMed         Abstract available

  14. DIAZ-CANESTRO C, Ng HF, Yiu KH, Montero D, et al
    Reduced lean body mass: a potential modifiable contributor to the pathophysiology of heart failure.
    Eur Heart J. 2023 Mar 16:ehad130. doi: 10.1093.
    PubMed        


    Eur J Heart Fail

  15. PAGNESI M, Adamo M, Ter Maaten JM, Beldhuis IE, et al
    Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial.
    Eur J Heart Fail. 2023 Mar 13. doi: 10.1002/ejhf.2820.
    PubMed         Abstract available

  16. SAITO Y, Obokata M, Harada T, Kagami K, et al
    Disproportionate exercise-induced pulmonary hypertension in relation to cardiac output in heart failure with preserved ejection fraction: a non-invasive echocardiographic study.
    Eur J Heart Fail. 2023 Mar 13. doi: 10.1002/ejhf.2821.
    PubMed         Abstract available

  17. PANDEY AK, Dhingra NK, Pandey A, Puar P, et al
    Efficacy of sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors for heart failure in black patients: a systematic review and meta-analysis of randomized controlled trials.
    Eur J Heart Fail. 2023 Mar 15. doi: 10.1002/ejhf.2825.
    PubMed        

  18. DOBBIN SJH, Shen L, Petrie MC, Packer M, et al
    Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials.
    Eur J Heart Fail. 2023 Mar 15. doi: 10.1002/ejhf.2818.
    PubMed         Abstract available

  19. ZANNAD F, Alikhaani J, Alikhaani S, Butler J, et al
    PATIENT REPORTED OUTCOME MEASURES AND PATIENT ENGAGEMENT IN HEART FAILURE CLINICAL TRIALS: MULTI-STAKEHOLDER PERSPECTIVES.
    Eur J Heart Fail. 2023 Mar 16. doi: 10.1002/ejhf.2828.
    PubMed         Abstract available

  20. FUDIM M, Parikh K, Ganesh A, Molinger J, et al
    Splanchnic Nerve Block with Botulinum Toxin for Therapy of Chronic Heart Failure - Mechanism of Action (SPONGE-HF).
    Eur J Heart Fail. 2023 Mar 16. doi: 10.1002/ejhf.2829.
    PubMed        


    Heart

  21. FORSYTH P, Beezer J, Bateman J
    Holistic approach to drug therapy in a patient with heart failure.
    Heart. 2023 Mar 10:heartjnl-2022-321764. doi: 10.1136/heartjnl-2022-321764.
    PubMed         Abstract available

  22. SCHLENKER KA, Steiner JM
    Expanding perspective: considering opioids in the management of dyspnoea in end-stage heart failure.
    Heart. 2023 Mar 10:heartjnl-2023-322436. doi: 10.1136/heartjnl-2023-322436.
    PubMed        

  23. KOSTOPOULOS G, Doundoulakis I, Toulis KA, Karagiannis T, et al
    Prognostic models for heart failure in patients with type 2 diabetes: a systematic review and meta-analysis.
    Heart. 2023 Mar 10:heartjnl-2022-322044. doi: 10.1136/heartjnl-2022-322044.
    PubMed         Abstract available


    Int J Cardiol

  24. YANG Q, Wu H, Liu D, Li Y, et al
    Discussion of a study on the role of EMS in prognosis of elderly patients with AHF.
    Int J Cardiol. 2023;377:91.
    PubMed        

  25. CHRISTOPH M, Marius S, Karl S, Friedrich K, et al
    Efficacy of CRT upgrade in pacemaker-induced cardiomyopathy in an outpatient clinic - Results of a prospective registry.
    Int J Cardiol. 2023;377:60-65.
    PubMed         Abstract available

  26. FERREIRA JP, Cleland JG, Girerd N, Rossignol P, et al
    Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.
    Int J Cardiol. 2023;377:86-88.
    PubMed         Abstract available

  27. KAWAJI T, Shiomi H, Bao B, Hojo S, et al
    Intracardiac energy inefficiency during atrial fibrillation rhythm with heart failure: Assessment by echo-vector flow mapping.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00392.
    PubMed         Abstract available

  28. HEEGAARD B, Deis T, Rossing K, Ersboll M, et al
    Diabetes mellitus and hemodynamics in advanced heart failure.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00341.
    PubMed         Abstract available

  29. BURGER PM, Koudstaal S, Dorresteijn JAN, Savarese G, et al
    Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease.
    Int J Cardiol. 2023 Mar 11:S0167-5273(23)00395.
    PubMed         Abstract available

  30. FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
    Prognostic implications of six-minute walking distance in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Mar 11:S0167-5273(23)00396.
    PubMed         Abstract available


    J Card Fail

  31. SHAHID I, Fonarow GC, Greene SJ
    Time to Quadruple Guideline-Directed Medical Therapy as a Key Performance Measure for Heart Failure.
    J Card Fail. 2023 Mar 14:S1071-9164(23)00069.
    PubMed        

  32. SOKOS G, Kido K, Panjrath G, Benton E, et al
    Multidisciplinary Care in Heart Failure Services.
    J Card Fail. 2023 Mar 13:S1071-9164(23)00067.
    PubMed         Abstract available

  33. KENNEDY SG, Gaggin HK
    Leveraging biomarkers for precision medicine in heart failure.
    J Card Fail. 2023 Mar 10:S1071-9164(23)00065.
    PubMed        

  34. BURKE MA
    Quantifying the eyeball test: grip strength at the nexus of frailty, cachexia and sarcopenia in heart failure.
    J Card Fail. 2023 Mar 10:S1071-9164(23)00066.
    PubMed        


    J Cardiol

  35. KINOSHITA M, Saito M, Inoue K, Nakagawa H, et al
    Role of the right ventricular contractile reserve during low-load exercise in predicting heart failure readmission.
    J Cardiol. 2023 Mar 8:S0914-5087(23)00049-7. doi: 10.1016/j.jjcc.2023.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  36. MOVAHEDI F, Padman R, Antaki JF
    Limitations of receiver operating characteristic curve on imbalanced data: Assist device mortality risk scores.
    J Thorac Cardiovasc Surg. 2023;165:1433-1442.
    PubMed         Abstract available


    PLoS One

  37. CALLAHAN K, Acharya Y, Hollenbeak CS
    Validity of ICD codes to identify do-not-resuscitate orders among older adults with heart failure: A single center study.
    PLoS One. 2023;18:e0283045.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: